ERBB2 and breast cancer: Higher serum urea concentrations have been shown to protect against overall cancer incidence and cancer mortality [35], which is consistent with the finding that salivary urea concentrations are elevated in the most prognostically favorable luminal A and B HER2-negative breast cancers.